These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1577631)

  • 1. [Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
    Seifert E; Schadel A; Haberkorn U; Strauss LG
    HNO; 1992 Mar; 40(3):90-3. PubMed ID: 1577631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic management of head and neck malignancies with positron emission tomography.
    Reisser C; Haberkorn U; Dimitrakopoulou-Strauss A; Seifert E; Strauss LG
    Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):272-6. PubMed ID: 7873142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
    Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
    J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
    Reisser C; Haberkorn U; Strauss LG
    J Otolaryngol; 1993 Aug; 22(4):231-8. PubMed ID: 8230373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
    Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy.
    Chepeha DB; Sacco AG; Oxford LE; Karamchandani R; Miller TH; Teknos TN; Bradford CR; Eisbruch A; Worden FM; Urba SG; Mukherji SK; Bui C; Frey KA; Wolf GT; Lee JS
    Head Neck; 2009 Apr; 31(4):452-60. PubMed ID: 19189338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with chemotherapy in patients with advanced head and neck cancer.
    Cripps C; Odell P; Danjoux C; Nichol J; de la Bastide Y; Barron P; Hardie J
    J Otolaryngol; 1985 Dec; 14(6):391-3. PubMed ID: 2416947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early response to chemotherapy in hypopharyngeal cancer: assessment with (11)C-methionine PET, correlation with morphologic response, and clinical outcome.
    Chesnay E; Babin E; Constans JM; Agostini D; Bequignon A; Regeasse A; Sobrio F; Moreau S
    J Nucl Med; 2003 Apr; 44(4):526-32. PubMed ID: 12679395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytostatic primary therapy of squamous cell carcinoma of the oro- and hypopharynx with cisplatin, bleomycin and methotrexate].
    Deitmer T; Urbanitz D
    Laryngol Rhinol Otol (Stuttg); 1986 Jan; 65(1):7-10. PubMed ID: 2419720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy.
    Berlangieri SU; Brizel DM; Scher RL; Schifter T; Hawk TC; Hamblen S; Coleman RE; Hoffman JM
    Head Neck; 1994; 16(4):340-6. PubMed ID: 8056579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current role for induction chemotherapy in head and neck tumors].
    Dietz A; Keilholz U; Werner J; Hagen R; Flentje M; Iro H
    Laryngorhinootologie; 2008 Apr; 87(4):237-43; discussion 244. PubMed ID: 18365986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [FDG-PET-CT based imaging of retropharyngeal lymph nodes with its impact on radiotherapy].
    Dietl B; Marienhagen J; Murthum T; Kölbl O
    Laryngorhinootologie; 2008 Jan; 87(1):39-42. PubMed ID: 17638170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of energy metabolism in ENT tumors--a PET study].
    Reisser C; Haberkorn U; Strauss LG
    HNO; 1992 Jun; 40(6):225-31. PubMed ID: 1634382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Medicine Approach for an Exceptional Response to Multiple-recurrent and Metastatic HER2-positive Oropharyngeal Squamous Cell Carcinoma.
    Seim NB; Kang SY; Bhandari M; Jones RG; Teknos TN
    Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):334-339. PubMed ID: 28061634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.
    Haberkorn U; Strauss LG; Dimitrakopoulou A; Seiffert E; Oberdorfer F; Ziegler S; Reisser C; Doll J; Helus F; van Kaick G
    J Nucl Med; 1993 Jan; 34(1):12-7. PubMed ID: 8418251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of positron emission tomography with the use of fluorodeoxyglucose on response to induction chemotherapy in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Kawakita D; Masui T; Hanai N; Ozawa T; Hirakawa H; Terada A; Nishio M; Hosoi H; Hasegawa Y
    Acta Otolaryngol; 2013 May; 133(5):523-30. PubMed ID: 23679812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors].
    Haberkorn U; Strauss LG; Reisser C; van Kaick G
    Radiologe; 1992 Jun; 32(6):296-301. PubMed ID: 1641487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional imaging of head and neck tumors using positron emission tomography.
    Zeitouni AG; Yamamoto YL; Black M; Gjedde A
    J Otolaryngol; 1994 Apr; 23(2):77-80. PubMed ID: 8028075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positron emission tomography in the detection of residual laryngeal carcinoma.
    Austin JR; Wong FC; Kim EE
    Otolaryngol Head Neck Surg; 1995 Oct; 113(4):404-7. PubMed ID: 7567012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Apropos of two recently published randomized trials of induction chemotherapy in nasopharyngeal and piriform sinus carcinoma].
    de Crevoisier R; Mazeron JJ
    Bull Cancer Radiother; 1996; 83(3):174-6. PubMed ID: 8977570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.